Cancer incidence and mortality in China, 2022
2024 · Journal of the National Cancer Center · 1,714 citations
https://doi.org/10.1016/j.jncc.2024.01.006
B
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
3.2K
Citations
17
h-index
20
i10-index
Bingfeng Han is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Global Cancer Incidence and Screening & Hepatitis B Virus Studies. The author has an h-index of 17, co-authored 70 publications.
ORCID: 0000-0002-6807-7026Papers by this author
works[Cancer incidence and mortality in China, 2022].
2024 · PubMed · 405 citations
https://doi.org/10.3760/cma.j.cn112152-20240119-00035
Cancer survival statistics in China 2019–2021: a multicenter, population-based study
2024 · Journal of the National Cancer Center · 97 citations
https://doi.org/10.1016/j.jncc.2024.06.005
Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050
2024 · The Lancet Regional Health - Western Pacific · 60 citations
https://doi.org/10.1016/j.lanwpc.2023.101003
Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation
2023 · The Lancet Regional Health - Western Pacific · 44 citations
https://doi.org/10.1016/j.lanwpc.2023.100738
Supplementary Figure 2 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
2024 · 0 citations
https://doi.org/10.1158/1055-9965.27030148.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat